优利德科技(中国)股份有限公司 投资者关系活动记录表 编号：2023-014 | 投资者关系 | ¨特定对象调研 ¨分析师会议 | ¨现场参观 | | --- | --- | --- | | 活动类别 | ¨媒体采访 þ 业绩说明会 ¨新闻发布会 | | | | ¨路演活动 ¨其他 | | | 参与单位名 | 通过线上方式参与公司 2023 | 年第三季度业绩说明会的投资者 | | 称 | | | | 时间 | 2023 年 12 月 1 日 | 10:00-11:00 | | 地点 | 上海证券交易所上证路演中心 | | | | （网址：http://roadshow.sseinfo.com/） | | | | 董事长、总经理 洪少俊先生 | | | 上市公司接 | 董事、副总经理、董事会秘书 周建华先生 | | | 待人员姓名 | 董事、副总经理、财务总监 张兴先生 | | | | 独立董事 杨月彬先生 | | | 投资者关系 | 公司于 2023 年 12 月 1 | 日在上海证券交易所上证路演中心召开 | | 活动主要内 容介绍 | 了 2023 年第三季度业绩说明会，通过网络文字互动的方式与投资者 ...

证券代码：688628 证券简称：优利德 公告编号：2023-049 优利德科技(中国)股份有限公司 董事集中竞价减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 大股东及董监高持股的基本情况 本次减持计划实施前，优利德科技（中国）股份有限公司（以下简称"公司"） 董事、副总经理、董事会秘书周建华先生持有公司股份 347,718 股，占公司总股 本的比例为 0.3149%，其中，通过持股平台拓利亚二期企业管理（东莞）中心（有 限合伙）间接持有 241,718 股；直接持有 106,000 股。 董事、副总经理、财务负责人张兴先生持有公司股份 226,669 股，占公司总 股本的比例为 0.2053%，其中，通过持股平台拓利亚二期企业管理（东莞）中心 （有限合伙）间接持有 120,669 股；直接持有 106,000 股。 董事甘宗秀女士持有公司股份 418,892 股，占公司总股本的比例为 0.3793%， 其中，通过持股平台拓利亚二期企业管理（东莞）中心（有限合伙）间接持有 3 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： （网址：http://roadshow.sseinfo.com） 证券代码：688628 证券简称：优利德 公告编号：2023-048 优利德科技(中国)股份有限公司 关于召开 2023 年第三季度业绩说明会的公告 会议召开方式：上证路演中心网络互动 投资者可于 2023 年 11 月 24 日(星期五) 至 11 月 30 日（星期四)16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 stock@uni-trend.com.cn 进行提问。公司将在说明会上对投资者普遍关注的问 题进行回答。 优利德科技(中国)股份有限公司（以下简称"公司"）已于 2023 年 10 月 27 日发布公司 2023 年第三季度报告，为便于广大投资者更全面深入地了解公司 2023 年第三季度经营成果、财务状况，公司计划于 2023 年 12 月 01 日 上午 10:00-11:00 举行 2023 年第三季度业绩说明会，就投资者关心的问题进行交流。 ...

证券代码：688628 证券简称：优利德 优利德科技(中国)股份有限公司 投资者关系活动记录表 编号：2023-013 þ特定对象调研 ¨分析师会议 þ现场参观 投资者关系 ¨媒体采访 ¨业绩说明会 ¨新闻发布会 活动类别 ¨路演活动 þ其他 券商策略会 开源证券、广发基金、安信证券、摩根士丹利基金、五矿证券、光大 参与单位名 保德信基金、广发机械、长江自营、博时基金、海雅金控、睿华资 称 本、珩道投资、中道投资 时间 2023年11月15日-11月17日 地点 深圳、公司会议室 上市公司接 董事、董事会秘书 周建华先生 待人员姓名 ...

Financial Performance - Revenue for the first three quarters of 2023 reached 7.84 billion yuan, a year-on-year increase of 12.61% [2] - Net profit attributable to shareholders was 1.32 billion yuan, up 42.43% year-on-year [2] - Third-quarter revenue was 2.39 billion yuan, a 36.74% increase [2] - Net cash flow from operating activities reached 190 million yuan, a 532.95% year-on-year increase [2] R&D Investment - R&D expenditure for the first three quarters totaled 70.18 million yuan, a 37.34% increase [2] - R&D spending accounted for 8.96% of total revenue [2] - R&D team expanded to 279 members, with over 150 specializing in instrument development [2] - Plans to continue increasing R&D personnel and maintain R&D investment growth aligned with revenue growth [3] Business Strategy Instrument Business - Focus on increasing sales proportion of mid-to-high-end products [3] - Implement annual price adjustment strategy for general instruments [3] - Develop targeted plans for professional instruments in power and new energy sectors [3] - Maintain parallel development across multiple product lines (time domain, frequency domain, source load, safety regulations) [3] - Plan annual generational upgrades for key product lines [3] Market Expansion - Domestic sales team exceeds 60 members, overseas team over 20 members [4] - German and US subsidiaries operational and contributing to revenue [4] - Continuously introducing professional instrument distributors globally [4] Growth Potential - Mid-to-high-end instruments show rapid revenue growth with significant market potential [3] - Domestic and global market share remains low, indicating substantial growth space [3] - Government policies provide favorable development opportunities for the industry [3] - Rich pipeline of R&D projects supports sustainable growth in mid-to-high-end instrument revenue [3]

证券代码：688628 证券简称：优利德 优利德科技(中国)股份有限公司 投资者关系活动记录表 编号：2023-011  特定对象调研 分析师会议  现场参观 投资者关系 媒体采访 业绩说明会 新闻发布会 活动类别 路演活动  其他 线上 汇添富基金、中银国际证券、长盛基金、天弘基金、生命保险、贝莱 德基金、宝盈基金、诺安基金、交银施罗德、光大保德信基金、鹏扬 基金、南方基金、鹏华基金、中金资管、浙江浙商证券资产管理有限 公司、长城财富保险资产管理股份有限公司、汇泉基金管理有限公司、 深圳市凯丰投资管理有限公司、建信保险资产管理有限公司、智合远 参与单位名 见、融通基金管理有限公司、嘉实基金、红土创新基金管理有限公司、 称 华泰柏瑞基金管理有限公司、方正资管、长江资管、农银汇理基金管 理有限公司、山东省鲁信投资控股集团、拾贝投资、国泰基金管理有 限公司、上海人寿保险股份有限公司、长信基金管理有限责任公司、 百嘉基金管理有限公司、九泰基金管理有限公司、兴业基金管理有限 公司、泰康资产、光大永明资产管理股份有限公司、上海聆泽私募基 金管理有限公司、中信建投证券股份有限公司 时间 2023年10 月 ...

证券代码：688628 证券简称：优利德 优利德科技(中国)股份有限公司 投资者关系活动记录表 编号：2023-010 特定对象调研 分析师会议 现场参观 投资者关系 媒体采访 业绩说明会 新闻发布会 活动类别 路演活动  其他 线上交流 平安基金管理有限公司、中欧基金管理有限公司、广发基金管理有限公司、新 华基金管理股份有限公司、百嘉基金管理有限公司、西部利得基金管理有限公 司、华泰保兴基金管理有限公司、光大保德信基金管理有限公司、申万菱信基 金管理有限公司、国融基金管理有限公司、信达澳亚基金管理有限公司、诺安 基金管理有限公司、工银瑞信基金管理有限公司、天弘基金管理有限公司、博 时基金管理有限公司、圆信永丰基金管理有限公司、兴业基金管理有限公司、 国寿安保基金管理有限公司、东兴基金管理有限公司、国金证券资产管理有限 公司、中信建投证券股份有限公司、国联证券股份有限公司、申万宏源证券有 限公司、广发证券股份有限公司、国元证券股份有限公司、德邦证券股份有限 公司、开源证券股份有限公司、招商证券股份有限公司、西南证券股份有限公 司、信达证券股份有限公司、东方财富证券股份有限公司、海通证券股份有限 ...

Financial Performance - The company's operating revenue for Q3 2023 reached ¥239,083,737.87, representing a year-over-year increase of 36.74%[4] - Net profit attributable to shareholders for Q3 2023 was ¥35,145,392.22, a significant increase of 124.38% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2023 was ¥35,955,638.25, up 141.65% year-over-year[4] - Total revenue for the first three quarters of 2023 reached ¥783,517,657.14, an increase of 12.6% compared to ¥695,760,111.61 in the same period of 2022[21] - Operating profit for the third quarter was ¥153,731,729.91, up from ¥107,601,565.02 in the previous year, reflecting a growth of 42.9%[22] - Net profit attributable to shareholders for the third quarter was ¥131,819,065.41, compared to ¥92,552,859.73 in the same quarter last year, representing an increase of 42.5%[22] - The total comprehensive income for the third quarter was ¥130,826,606.55, compared to ¥95,403,861.44 in the previous year, indicating a growth of 37.0%[23] - The net profit for the first three quarters of 2023 is expected to show a significant improvement compared to the previous year, driven by increased operational efficiency and market expansion strategies[32] - The company’s total comprehensive income for the first three quarters of 2023 was ¥139,689,552.07, up from ¥95,634,408.32 in 2022, indicating a growth of 46.0%[34] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥1,414,624,931.44, reflecting a 16.18% increase from the end of the previous year[5] - As of September 30, 2023, the total assets of the company reached CNY 1,414,624,931.44, an increase from CNY 1,217,653,735.96 at the end of 2022, reflecting a growth of approximately 16.2%[17] - The company's total liabilities increased to ¥253,753,700.64 in Q3 2023, compared to ¥158,573,119.81 in Q3 2022, marking a rise of 60%[20] - The company's total liabilities as of September 30, 2023, were ¥221,708,566.66, up from ¥116,935,258.92 at the end of 2022, showing an increase of 89.5%[30] Equity and Earnings - The total equity attributable to shareholders at the end of the reporting period was ¥1,162,407,606.21, a 9.80% increase from the previous year[5] - The total equity attributable to shareholders reached ¥1,162,407,606.21, an increase from ¥1,058,684,820.32 year-over-year, reflecting a growth of 9.8%[20] - The basic earnings per share for Q3 2023 was ¥0.32, an increase of 128.57% year-over-year[5] - The company reported a basic earnings per share of ¥1.19 for the third quarter, compared to ¥0.84 in the same period last year, representing an increase of 41.7%[23] Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥190,125,078.34, indicating a significant increase due to higher sales revenue[10] - Operating cash flow for the first three quarters of 2023 reached ¥190,125,078.34, a significant increase from ¥30,037,810.51 in the same period of 2022, representing a growth of 532.5%[26] - Cash flow from operating activities for the first three quarters of 2023 was ¥187,651,864.85, significantly higher than ¥42,370,724.09 in 2022[36] - The total cash and cash equivalents at the end of the third quarter of 2023 amounted to ¥289,106,459.95, compared to ¥90,607,378.33 at the end of the same period in 2022[36] Research and Development - The company's R&D investment for Q3 2023 was ¥25,279,955.17, which is 32.91% higher than the same period last year[5] - Research and development expenses for the first three quarters amounted to ¥70,182,017.67, up from ¥51,102,716.57 in the previous year, indicating a growth of 37.3%[21] - Research and development expenses increased to ¥57,748,350.57 in 2023, up from ¥42,842,172.60 in 2022, marking a rise of 34.8%[33] Market Strategy - The company plans to continue enhancing its product structure and pricing strategy to drive future growth[10] - The company is focusing on expanding its market presence and developing new products, although specific figures were not disclosed in the conference call[15] - The company plans to continue investing in new product development and market expansion initiatives to sustain growth momentum in the upcoming quarters[32]

Group 1: Market Development - The company has expanded its sales team and market development efforts, forming intentions for orders or repeat purchases with 119 listed companies, 162 central and state-owned enterprises, and 118 universities and research institutions in the first half of 2023 [2] - The company has successfully tapped into various industries, including new energy, consumer electronics, telecommunications, automotive electronics, aerospace, and research institutions, leading to a significant increase in order volume [2] Group 2: Profit Margin Improvement - The main reason for the continuous improvement in gross profit margin is the enhancement of product structure, driven by increased sales revenue and proportion of high-margin professional instruments and testing equipment [2] - Factors such as product price increases, declining raw material costs, and exchange rate fluctuations have also positively impacted the gross profit margin [2] Group 3: Growth Potential of High-End Instruments - The market share of mid-to-high-end instruments is currently low, indicating significant growth potential for domestic instrument manufacturers in both domestic and global markets, supported by favorable national policies [3] - The company has established a certain level of technical accumulation in its mid-to-high-end instrument product line, with a rich pipeline of research projects, which is expected to sustain revenue growth [3] Group 4: Competitive Advantage in Instrument Market - The company plans to maintain R&D expenditure at around 8% of annual revenue, focusing on recruiting high-level R&D personnel and increasing R&D efforts, which have doubled compared to 2020 [3] - The company aims to enhance its international presence by increasing the number of experienced sales personnel and establishing offices in Europe and North America to facilitate market entry [3] Group 5: Performance Forecast - The company's performance target for 2023 is set at no less than 180 million yuan, with a net profit attributable to shareholders of 96.67 million yuan achieved in the first half of 2023 [3]

优利德科技（中国）股份有限公司 章 程 二〇二三年八月 1 | - | 2 | | --- | --- | | 1 | | | 第一章 | 总则 3 | | --- | --- | | 第二章 | 经营宗旨和范围 4 | | 第三章 | 股份 4 | | 第一节 | 股份发行 4 | | 第二节 | 股份增减和回购 6 | | 第三节 | 股份转让 7 | | 第四章 | 股东和股东大会 8 | | 第一节 | 股东 8 | | 第二节 | 股东大会的一般规定 11 | | 第三节 | 股东大会的召集 14 | | 第四节 | 股东大会的提案与通知 15 | | 第五节 | 股东大会的召开 17 | | 第六节 | 股东大会的表决和决议 21 | | 第五章 | 董事会 26 | | 第一节 | 董事 26 | | 第二节 | 董事会 29 | | 第六章 | 总经理及其他高级管理人员 35 | | 第七章 | 监事会 37 | | 第一节 | 监事 37 | | 第二节 | 监事会 38 | | 第八章 | 财务会计制度、利润分配和审计 39 | | 第一节 | 财务会计制度、利润分配 40 | | 第二节 ...